Senior Care Services.Org

  Home                            About Us                  Contact                        Website Map 


 

 

 Alzheimer’s Treatment: Experimental Therapies and Alternative

Treatments 

 

Alzheimer’s treatment: Experimental therapies 

Although the reason is not clear, enrollment in clinical trials frequently seems to delay the progression of Alzheimer’s disease.  Some experts state that there could be several explanations for this effect. It could be due to the direct effect of the drug being studied or to improved coping skills that caregivers receive from contact with medical personnel during the study.  Whatever the reason for the delay in the progression of the disease, it is believed that Alzheimer’s disease patients receive more benefits for enrolling in clinical trials than most other medical conditions, since there is currently no cure for Alzheimer’s disease.  

The focus of research at this point in time is on delaying the onset of the disease.  The following are currently being researched in terms of their usefulness as preventive agents.  The following treatments are believed to hold hope for the future, although they are still regarded as highly experimental at the present time.

Anti-inflammatory drugs: 

Many experts consider the nonsteroidal anti-inflammatory drugs (NSAIDs) to be showing some promise as preventive therapies.  These medications are commonly used to treat rheumatoid arthritis. While medical researchers are not sure how they work, it is hypothesized that NSAIDs may possibly provide protection against inflammation associated with Alzheimer’s disease, or may have some effect on the delivery of blood to the brain.

Ginkgo biloba as an Alzheimer’s treatment: 

Although it is not clear how ginkgo biloba works, it has been found that patients taking this extract have sometimes had a slower decline in cognitive abilities then patients who received a placebo.  The American Academy of Neurology has concluded that although the evidence is relatively weak, some studies have found that some patients with other types of dementia (not Alzheimer’s disease) may benefit.  Ginkgo biloba is not regulated by the FDA and is therefore not considered a food supplement.  Also, it is important to note that when aspirin is taken at the same time as ginkgo biloba there may also be an increased risk in bleeding.

 

Also, See: Alzheimer’s Treatment: Medications and Vitamin E

 

Information from The Johns Hopkins Medical Guide to Health After 50

Additional Information and webpage by Paul Susic MA Licensed Psychologist Ph.D. Candidate                                      

Recommend this Page on Google Plus 

Google
 
Web www.SeniorCareServices.Org

Copyright 2004 Senior Care Psychological Consulting    2451 Executive Dr. Ste. 103 St. Charles, Missouri 63303    (636) 896-0216